231 related articles for article (PubMed ID: 28957820)
1. Risk Factors of Gastrointestinal Bleeding After Continuous Flow Left Ventricular Assist Device.
Balcioglu O; Kemal HS; Ertugay S; Ozturk P; Engin Y; Nalbantgil S; Engin C; Yagdi T; Ozbaran M
ASAIO J; 2018; 64(4):458-461. PubMed ID: 28957820
[TBL] [Abstract][Full Text] [Related]
2. Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device.
Meyer AL; Malehsa D; Budde U; Bara C; Haverich A; Strueber M
JACC Heart Fail; 2014 Apr; 2(2):141-5. PubMed ID: 24720921
[TBL] [Abstract][Full Text] [Related]
3. Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pump.
Goda M; Jacobs S; Rega F; Peerlinck K; Jacquemin M; Droogne W; Vanhaecke J; Van Cleemput J; Van den Bossche K; Meyns B
J Heart Lung Transplant; 2013 May; 32(5):539-45. PubMed ID: 23570742
[TBL] [Abstract][Full Text] [Related]
4. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients.
Crow S; Chen D; Milano C; Thomas W; Joyce L; Piacentino V; Sharma R; Wu J; Arepally G; Bowles D; Rogers J; Villamizar-Ortiz N
Ann Thorac Surg; 2010 Oct; 90(4):1263-9; discussion 1269. PubMed ID: 20868825
[TBL] [Abstract][Full Text] [Related]
5. Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation.
Kang J; Zhang DM; Restle DJ; Kallel F; Acker MA; Atluri P; Bartoli CR
J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1747-1754.e1. PubMed ID: 26971377
[TBL] [Abstract][Full Text] [Related]
6. Association between the severity of acquired von Willebrand syndrome and gastrointestinal bleeding after continuous-flow left ventricular assist device implantation.
Sakatsume K; Saito K; Akiyama M; Sasaki K; Kawatsu S; Takahashi G; Adachi O; Kawamoto S; Horiuchi H; Saiki Y
Eur J Cardiothorac Surg; 2018 Nov; 54(5):841-846. PubMed ID: 29741685
[TBL] [Abstract][Full Text] [Related]
7. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.
Uriel N; Pak SW; Jorde UP; Jude B; Susen S; Vincentelli A; Ennezat PV; Cappleman S; Naka Y; Mancini D
J Am Coll Cardiol; 2010 Oct; 56(15):1207-13. PubMed ID: 20598466
[TBL] [Abstract][Full Text] [Related]
8. Detection of acquired von Willebrand syndrome after ventricular assist device by total thrombus-formation analysis system.
Takashio S; Kaikita K; Nishi M; Morioka M; Higo T; Shiose A; Doman T; Horiuchi H; Fukui T; Tsujita K
ESC Heart Fail; 2020 Oct; 7(5):3235-3239. PubMed ID: 32700467
[TBL] [Abstract][Full Text] [Related]
9. Intractable bleeding tendency due to acquired von Willebrand syndrome after Jarvik 2000 implant.
Sakatsume K; Akiyama M; Saito K; Kawamoto S; Horiuchi H; Saiki Y
J Artif Organs; 2016 Sep; 19(3):289-92. PubMed ID: 27021290
[TBL] [Abstract][Full Text] [Related]
10. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.
Geisen U; Heilmann C; Beyersdorf F; Benk C; Berchtold-Herz M; Schlensak C; Budde U; Zieger B
Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712
[TBL] [Abstract][Full Text] [Related]
11. Increased cyclic guanosine monophosphate levels and continuous-flow left-ventricular assist devices: Implications for gastrointestinal bleeding.
Grosman-Rimon L; Tumiati LC; Fuks A; Jacobs I; Lalonde SD; Cherney DZ; Rao V
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):219-27. PubMed ID: 26515873
[TBL] [Abstract][Full Text] [Related]
12. Development of acquired von Willebrand syndrome during short-term micro axial pump support: implications for bleeding in a patient bridged to a long-term continuous-flow left ventricular assist device.
Davis ME; Haglund NA; Tricarico NM; Keebler ME; Maltais S
ASAIO J; 2014; 60(3):355-7. PubMed ID: 24614358
[TBL] [Abstract][Full Text] [Related]
13. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA
Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure.
Netuka I; Kvasnička T; Kvasnička J; Hrachovinová I; Ivák P; Mareček F; Bílková J; Malíková I; Jančová M; Malý J; Sood P; Sundareswaran KS; Connors JM; Mehra MR
J Heart Lung Transplant; 2016 Jul; 35(7):860-7. PubMed ID: 27435529
[TBL] [Abstract][Full Text] [Related]
15. Effects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian center.
Esmaeilzadeh F; Wauters A; Wijns W; Argacha JF; van de Borne P
BMC Cardiovasc Disord; 2016 Aug; 16(1):155. PubMed ID: 27485105
[TBL] [Abstract][Full Text] [Related]
16. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices.
Birschmann I; Dittrich M; Eller T; Wiegmann B; Reininger AJ; Budde U; Strüber M
J Heart Lung Transplant; 2014 Jan; 33(1):80-7. PubMed ID: 24418734
[TBL] [Abstract][Full Text] [Related]
17. Immediate recovery of acquired von Willebrand syndrome after left ventricular assist device explantation: implications for heart transplantation.
Davis ME; Haglund NA; Tricarico NM; Matafonov A; Gailani D; Maltais S
ASAIO J; 2015; 61(1):e1-4. PubMed ID: 25251586
[TBL] [Abstract][Full Text] [Related]
18. Platelet dysfunction and acquired von Willebrand syndrome in patients with left ventricular assist devices.
Baghai M; Heilmann C; Beyersdorf F; Nakamura L; Geisen U; Olschewski M; Zieger B
Eur J Cardiothorac Surg; 2015 Sep; 48(3):421-7. PubMed ID: 25543177
[TBL] [Abstract][Full Text] [Related]
19. Is anti-platelet therapy needed in continuous flow left ventricular assist device patients? A single-centre experience.
Litzler PY; Smail H; Barbay V; Nafeh-Bizet C; Bouchart F; Baste JM; Abriou C; Bessou JP
Eur J Cardiothorac Surg; 2014 Jan; 45(1):55-9; discussion 59-60. PubMed ID: 23671203
[TBL] [Abstract][Full Text] [Related]
20. von Willebrand Factor Abnormalities and Heyde Syndrome in Dysfunctional Heart Valve Prostheses.
Blackshear JL; McRee CW; Safford RE; Pollak PM; Stark ME; Thomas CS; Rivera CE; Wysokinska EM; Chen D
JAMA Cardiol; 2016 May; 1(2):198-204. PubMed ID: 27437891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]